Global Biochips (Microarrays & Microfluidics) Market Growth 2024-2030

Publication ID:

LPI09244024

Publication Date:

September 9, 2024

Pages:

117

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Biochips (Microarrays & Microfluidics) market size was valued at US$ million in 2023. With growing demand in downstream market, the Biochips (Microarrays & Microfluidics) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Biochips (Microarrays & Microfluidics) market. Biochips (Microarrays & Microfluidics) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biochips (Microarrays & Microfluidics). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biochips (Microarrays & Microfluidics) market.
Following a strong growth of 26.2 percent in the year 2021, WSTS revised it down to a single digit growth for the worldwide semiconductor market in 2022 with a total size of US$580 billion, up 4.4 percent. WSTS lowered growth estimation as inflation rises and end markets seeing weaker demand, especially those exposed to consumer spending. While some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.8 percent, Sensors with 16.3 percent, and Logic with 14.5 percent growth. Memory declined with 12.6 percent year over year. In 2022, all geographical regions showed double-digit growth except Asia Pacific. The largest region, Asia Pacific, declined 2.0 percent. Sales in the Americas were US$142.1 billion, up 17.0% year-on-year, sales in Europe were US$53.8 billion, up 12.6% year-on-year, and sales in Japan were US$48.1 billion, up 10.0% year-on-year. However, sales in the largest Asia-Pacific region were US$336.2 billion, down 2.0% year-on-year.
Key Features:
The report on Biochips (Microarrays & Microfluidics) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Biochips (Microarrays & Microfluidics) market. It may include historical data, market segmentation by Type (e.g., DNA Chip, Lab-on-a-chip), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biochips (Microarrays & Microfluidics) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biochips (Microarrays & Microfluidics) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biochips (Microarrays & Microfluidics) industry. This include advancements in Biochips (Microarrays & Microfluidics) technology, Biochips (Microarrays & Microfluidics) new entrants, Biochips (Microarrays & Microfluidics) new investment, and other innovations that are shaping the future of Biochips (Microarrays & Microfluidics).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biochips (Microarrays & Microfluidics) market. It includes factors influencing customer ' purchasing decisions, preferences for Biochips (Microarrays & Microfluidics) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biochips (Microarrays & Microfluidics) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biochips (Microarrays & Microfluidics) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biochips (Microarrays & Microfluidics) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biochips (Microarrays & Microfluidics) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biochips (Microarrays & Microfluidics) market.
Market Segmentation:
Biochips (Microarrays & Microfluidics) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
DNA Chip
Lab-on-a-chip
Protein Chip
Segmentation by application
Academics Institutes
Diagnostics Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Agilent
PerkinElmer
Fluidigm
Illumina
GE Healthcare
Bio-Rad Laboratories
Cepheid
Thermo Fisher
Roche
Key Questions Addressed in this Report
What is the 10-year outlook for the global Biochips (Microarrays & Microfluidics) market?
What factors are driving Biochips (Microarrays & Microfluidics) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Biochips (Microarrays & Microfluidics) market opportunities vary by end market size?
How does Biochips (Microarrays & Microfluidics) break out type, application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biochips (Microarrays & Microfluidics) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Biochips (Microarrays & Microfluidics) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Biochips (Microarrays & Microfluidics) by Country/Region, 2019, 2023 & 2030
2.2 Biochips (Microarrays & Microfluidics) Segment by Type
2.2.1 DNA Chip
2.2.2 Lab-on-a-chip
2.2.3 Protein Chip
2.3 Biochips (Microarrays & Microfluidics) Sales by Type
2.3.1 Global Biochips (Microarrays & Microfluidics) Sales Market Share by Type (2019-2024)
2.3.2 Global Biochips (Microarrays & Microfluidics) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Biochips (Microarrays & Microfluidics) Sale Price by Type (2019-2024)
2.4 Biochips (Microarrays & Microfluidics) Segment by Application
2.4.1 Academics Institutes
2.4.2 Diagnostics Centers
2.5 Biochips (Microarrays & Microfluidics) Sales by Application
2.5.1 Global Biochips (Microarrays & Microfluidics) Sale Market Share by Application (2019-2024)
2.5.2 Global Biochips (Microarrays & Microfluidics) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Biochips (Microarrays & Microfluidics) Sale Price by Application (2019-2024)
3 Global Biochips (Microarrays & Microfluidics) by Company
3.1 Global Biochips (Microarrays & Microfluidics) Breakdown Data by Company
3.1.1 Global Biochips (Microarrays & Microfluidics) Annual Sales by Company (2019-2024)
3.1.2 Global Biochips (Microarrays & Microfluidics) Sales Market Share by Company (2019-2024)
3.2 Global Biochips (Microarrays & Microfluidics) Annual Revenue by Company (2019-2024)
3.2.1 Global Biochips (Microarrays & Microfluidics) Revenue by Company (2019-2024)
3.2.2 Global Biochips (Microarrays & Microfluidics) Revenue Market Share by Company (2019-2024)
3.3 Global Biochips (Microarrays & Microfluidics) Sale Price by Company
3.4 Key Manufacturers Biochips (Microarrays & Microfluidics) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biochips (Microarrays & Microfluidics) Product Location Distribution
3.4.2 Players Biochips (Microarrays & Microfluidics) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Biochips (Microarrays & Microfluidics) by Geographic Region
4.1 World Historic Biochips (Microarrays & Microfluidics) Market Size by Geographic Region (2019-2024)
4.1.1 Global Biochips (Microarrays & Microfluidics) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Biochips (Microarrays & Microfluidics) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Biochips (Microarrays & Microfluidics) Market Size by Country/Region (2019-2024)
4.2.1 Global Biochips (Microarrays & Microfluidics) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Biochips (Microarrays & Microfluidics) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biochips (Microarrays & Microfluidics) Sales Growth
4.4 APAC Biochips (Microarrays & Microfluidics) Sales Growth
4.5 Europe Biochips (Microarrays & Microfluidics) Sales Growth
4.6 Middle East & Africa Biochips (Microarrays & Microfluidics) Sales Growth
5 Americas
5.1 Americas Biochips (Microarrays & Microfluidics) Sales by Country
5.1.1 Americas Biochips (Microarrays & Microfluidics) Sales by Country (2019-2024)
5.1.2 Americas Biochips (Microarrays & Microfluidics) Revenue by Country (2019-2024)
5.2 Americas Biochips (Microarrays & Microfluidics) Sales by Type
5.3 Americas Biochips (Microarrays & Microfluidics) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biochips (Microarrays & Microfluidics) Sales by Region
6.1.1 APAC Biochips (Microarrays & Microfluidics) Sales by Region (2019-2024)
6.1.2 APAC Biochips (Microarrays & Microfluidics) Revenue by Region (2019-2024)
6.2 APAC Biochips (Microarrays & Microfluidics) Sales by Type
6.3 APAC Biochips (Microarrays & Microfluidics) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Biochips (Microarrays & Microfluidics) by Country
7.1.1 Europe Biochips (Microarrays & Microfluidics) Sales by Country (2019-2024)
7.1.2 Europe Biochips (Microarrays & Microfluidics) Revenue by Country (2019-2024)
7.2 Europe Biochips (Microarrays & Microfluidics) Sales by Type
7.3 Europe Biochips (Microarrays & Microfluidics) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biochips (Microarrays & Microfluidics) by Country
8.1.1 Middle East & Africa Biochips (Microarrays & Microfluidics) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Biochips (Microarrays & Microfluidics) Revenue by Country (2019-2024)
8.2 Middle East & Africa Biochips (Microarrays & Microfluidics) Sales by Type
8.3 Middle East & Africa Biochips (Microarrays & Microfluidics) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Biochips (Microarrays & Microfluidics)
10.3 Manufacturing Process Analysis of Biochips (Microarrays & Microfluidics)
10.4 Industry Chain Structure of Biochips (Microarrays & Microfluidics)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Biochips (Microarrays & Microfluidics) Distributors
11.3 Biochips (Microarrays & Microfluidics) Customer
12 World Forecast Review for Biochips (Microarrays & Microfluidics) by Geographic Region
12.1 Global Biochips (Microarrays & Microfluidics) Market Size Forecast by Region
12.1.1 Global Biochips (Microarrays & Microfluidics) Forecast by Region (2025-2030)
12.1.2 Global Biochips (Microarrays & Microfluidics) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Biochips (Microarrays & Microfluidics) Forecast by Type
12.7 Global Biochips (Microarrays & Microfluidics) Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Biochips (Microarrays & Microfluidics) Product Portfolios and Specifications
13.1.3 Abbott Biochips (Microarrays & Microfluidics) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Agilent
13.2.1 Agilent Company Information
13.2.2 Agilent Biochips (Microarrays & Microfluidics) Product Portfolios and Specifications
13.2.3 Agilent Biochips (Microarrays & Microfluidics) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Agilent Main Business Overview
13.2.5 Agilent Latest Developments
13.3 PerkinElmer
13.3.1 PerkinElmer Company Information
13.3.2 PerkinElmer Biochips (Microarrays & Microfluidics) Product Portfolios and Specifications
13.3.3 PerkinElmer Biochips (Microarrays & Microfluidics) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 PerkinElmer Main Business Overview
13.3.5 PerkinElmer Latest Developments
13.4 Fluidigm
13.4.1 Fluidigm Company Information
13.4.2 Fluidigm Biochips (Microarrays & Microfluidics) Product Portfolios and Specifications
13.4.3 Fluidigm Biochips (Microarrays & Microfluidics) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Fluidigm Main Business Overview
13.4.5 Fluidigm Latest Developments
13.5 Illumina
13.5.1 Illumina Company Information
13.5.2 Illumina Biochips (Microarrays & Microfluidics) Product Portfolios and Specifications
13.5.3 Illumina Biochips (Microarrays & Microfluidics) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Illumina Main Business Overview
13.5.5 Illumina Latest Developments
13.6 GE Healthcare
13.6.1 GE Healthcare Company Information
13.6.2 GE Healthcare Biochips (Microarrays & Microfluidics) Product Portfolios and Specifications
13.6.3 GE Healthcare Biochips (Microarrays & Microfluidics) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 GE Healthcare Main Business Overview
13.6.5 GE Healthcare Latest Developments
13.7 Bio-Rad Laboratories
13.7.1 Bio-Rad Laboratories Company Information
13.7.2 Bio-Rad Laboratories Biochips (Microarrays & Microfluidics) Product Portfolios and Specifications
13.7.3 Bio-Rad Laboratories Biochips (Microarrays & Microfluidics) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Bio-Rad Laboratories Main Business Overview
13.7.5 Bio-Rad Laboratories Latest Developments
13.8 Cepheid
13.8.1 Cepheid Company Information
13.8.2 Cepheid Biochips (Microarrays & Microfluidics) Product Portfolios and Specifications
13.8.3 Cepheid Biochips (Microarrays & Microfluidics) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Cepheid Main Business Overview
13.8.5 Cepheid Latest Developments
13.9 Thermo Fisher
13.9.1 Thermo Fisher Company Information
13.9.2 Thermo Fisher Biochips (Microarrays & Microfluidics) Product Portfolios and Specifications
13.9.3 Thermo Fisher Biochips (Microarrays & Microfluidics) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Thermo Fisher Main Business Overview
13.9.5 Thermo Fisher Latest Developments
13.10 Roche
13.10.1 Roche Company Information
13.10.2 Roche Biochips (Microarrays & Microfluidics) Product Portfolios and Specifications
13.10.3 Roche Biochips (Microarrays & Microfluidics) Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Roche Main Business Overview
13.10.5 Roche Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂